From: CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy
Location
Well (%)
Moderate (%)
Poor (%)
Total (%)
Colon
9 (6.00)
121 (80.66)
20 (13.33)
150 (100)
Rectum
7 (5.78)
104 (85.95)
10 (8.26)
121 (100)
Total
16 (5.90)
225 (83.02)
30 (11.07)
271 (100)